Zymeworks (ZYME) Misses Q1 EPS by 30c

Zymeworks (NASDAQ: ZYME) reported Q1 EPS of ($0.30). Revenue for the quarter came in at $27.1 million.

For earnings history and earnings-related data on Zymeworks (ZYME) click here.

You May Also Be Interested In

• Ericsson (ERIC) Tops Q2 EPS by 3c
• Berenberg Downgrades QIAGEN NV (QIA:GR) (QGEN) to Hold
• Morgan Stanley Downgrades Tryg A/S (TRYG:DC) (TGVSF) to Underweight